6.17), hydralazine and procainamide metabolism and NAT1, which is more specific for p-aminosalicylate, p-aminobenzoic acid and the folate metabolite, p-aminobenzoylglutamate (Sim et al., 2014
10.1073/pnas.0510565103 Proc
However, it is not FDA-approved for general medical use and remains classified for research purposes
Accessed 3 Sep 2021 Mendiola AS, Cardona AE (2018) The IL-1 phenomena in neuroinflammatory diseases
Conclusion We have found that insulin and GLP-1 secretions share striking commonalities in signaling, yet each exhibits different unique properties that may have developed evolutionarily and purposefully
If your provider agrees it is a suitable option, they can contact us directly for more information and to place a prescription